Literature DB >> 17464724

Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans.

Elizabeth E Roughead1, Brian McDermott, Andrew L Gilbert.   

Abstract

OBJECTIVE: This study assessed the prevalence of duplicate antidepressant prescribing and avoidable potential antidepressant drug interactions in the Australian war veteran population.
METHOD: The Department of Veterans' Affairs Pharmacy Claims database was interrogated, using specific criteria, to identify antidepressant duplication. In addition, potential drug interactions where safer alternative therapies were available were assessed. These included anticholinergic agents with tricyclic antidepressants and tramadol with antidepressants. Episodic tramadol dispensings with antidepressants were also assessed.
RESULTS: A total of 46,859 veterans had antidepressants regularly dispensed to them in the period 1 April-31 July 2005. Overall, 4037 potential interactions were identified in 3818 veterans (8.1%) to whom were dispensed antidepressants regularly. Antidepressant and tramadol co-prescribing was the most common potential interaction identified among 3.6% of veterans. Two or more interactions were identified in 212 veterans (0.5%). Analysis of episodic tramadol dispensings with antidepressants suggested a much higher prevalence of 7.7%.
CONCLUSION: The increasing use of antidepressants and the high level of potentially avoidable interactions detected in the present study, highlight the necessity of ongoing vigilance concerning the use of potentially inappropriate drug combinations, particularly in the elderly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464724     DOI: 10.1080/00048670701213294

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

1.  Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data.

Authors:  Clare Ringland; Andrea Mant; Patricia McGettigan; Philip Mitchell; Christopher Kelman; Nicholas Buckley; Sallie-Anne Pearson
Journal:  Br J Clin Pharmacol       Date:  2008-07-08       Impact factor: 4.335

2.  Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Authors:  Jonathan Brett; Benjamin Daniels; Emily A Karanges; Nicholas A Buckley; Carl Schneider; Atheer Nassir; Andrew J McLachlan; Sallie-Anne Pearson
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

3.  Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction.

Authors:  Nora M Hagelberg; Tuukka Saarikoski; Teijo I Saari; Mikko Neuvonen; Pertti J Neuvonen; Miia Turpeinen; Mika Scheinin; Kari Laine; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2012-10-26       Impact factor: 2.953

4.  Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-04

Review 5.  Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases.

Authors:  Christine Y Lu
Journal:  Clin Rheumatol       Date:  2009-02-04       Impact factor: 2.980

6.  The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.

Authors:  Sallie-Anne Pearson; Andrea Schaffer
Journal:  BMJ Open       Date:  2014-05-02       Impact factor: 2.692

7.  The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy.

Authors:  Michael J Leach; Nicole L Pratt; Elizabeth E Roughead
Journal:  Drugs Real World Outcomes       Date:  2017-12

8.  Polypharmacy in Australian Veterans with Post-traumatic Stress Disorder upon Admission to a Mental Health Facility: A Retrospective Chart Review.

Authors:  Rebecca Mellor; Andrew Khoo; Elise Saunders-Dow; Ella Raguz; Meng-Wong Taing; Leila Shafiee Hanjani; Chris Freeman; Darrell Crawford
Journal:  Drugs Real World Outcomes       Date:  2022-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.